McAdam »

Compass Therapeutics shares owned by McAdam

Quarter-by-quarter ownership of Compass Therapeutics (CMPX) shares owned by McAdam from 13F filings

Historical chart of McAdam investment in Compass Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Compass Therapeutics held by McAdam consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Compass Therapeutics by McAdam

Quarter filed Position value Share count Share price at filing
2026-09-30 $21k 20k 1.04
2026-06-30 $36k 17k 2.19

More positions owned by McAdam

Schwab Strategic Tr Fundamental Us L (FNDX)
Schwab Strategic Tr Us Lrg Cap Etf (SCHX)
Schwab Strategic Tr Us Lcap Gr Etf (SCHG)
Schwab Strategic Tr Intl Eqty Etf (SCHF)
Schwab Strategic Tr Intl Sceqt Etf (SCHC)
Fidelity Covington Trust Emerg Mkts Mltft (FDEM)
J P Morgan Exchange Traded F Core Plus Bd Etf (JCPB)
Vanguard Index Fds Mrngstr Md Cp Va (VOE)
Vanguard Index Fds MRNGSTR MD CP GR (VOT)
Schwab Strategic Tr Us Aggregate B (SCHZ)
Apple (AAPL)
NVIDIA Corporation (NVDA)
Vanguard Index Fds MRNGSTR SML CP V (VBR)
Ishares Tr Core S&p500 Etf (IVV)
Vanguard Index Fds MRNGSTR SM CP GR (VBK)

View all positions for McAdam

Top funds holding Compass Therapeutics

Tang Capital Management
OrbiMed Advisors
Suvretta Capital Management
BlackRock
State Street Corporation
Enavate Sciences GP
Vivo Capital
Vanguard Capital Management
Palo Alto Investors
Millennium Management
Geode Capital Management
Vanguard Portfolio Management
Citadel Advisors
Qube Research & Technologies
Blue Owl Capital Holdings

View all funds holding Compass Therapeutics